ORION Biotech Catalyst Calendar
Menu
Skip to company dates

Verastem (VSTM) pipeline and stated timing

Name in SEC filings: Verastem, Inc.

Pipeline at a glance

ProgramEventStageStated timingFiling
VS-7375/data readoutStage not statedOctober 20268-K ·

Source: ORION, orionbiotechai.com/company/VSTM, data as of Oct 18, 2026
https://www.orionbiotechai.com/company/VSTM

Latest retained statement: VS-7375 · Topline/data readout · October 2026 · filed

SEC sources last checked .

Programs and stated timing

○ Quote matched to filing (not yet reviewed by founder) · ✓ Checked by founder.

How this date was described over time

Company periods and sentences are quoted as written. A matching disclosure uses the SEC filing date for the same program and event type. As of .

Program / eventStated period and SEC wordingDisclosure in stated period
VS-7375Clinical resultsOctober 2026
“Report updated VS-7375 clinical data in October 2026.”

Filed · EX-99.1

Disclosure present

SEC filing date within the stated period

Filed · 8-K

“On October 14, 2026, the Company issued a press release announcing initial efficacy and updated safety and tolerability data in first multi-clinical cancer data update from the ongoing TARGET-D 101 Phase 1/2 clinical trial evaluating VS-7375, an oral KRAS G12D (ON/OFF) inhibitor, in patients with advanced KRAS G12D-mutated solid tumors, a copy of which is furnished hereto as Exhibit 99.2 to this Current Report on Form 8-K.”

“Not compared” means ORION has not matched this wording against a complete set of SEC filings for its period. It says nothing either way about whether a matching filing exists. Wording without exact dates is not given calendar dates.

Watch VSTM

Or email ORION to ask for this Watch.

Request another SEC timing statement

Suggest an SEC timing statement to add for VSTM. You can include the original filing link in your note. The founder reads each request by hand.

Or email ORION.

Reading these records

First stated window
The timing wording in the earliest company statement located within the sources checked, quoted as written (for example “2H 2026”). An earlier statement may exist outside those sources.
Disclosure date
The date of the filing or company release that disclosed the readout. “None found” means no such disclosure was located in the sources checked. SEC filings were searched through the “SEC filings searched through” date shown.
1H, 2H, 1Q–4Q
First or second half, or first to fourth quarter, of the year named, as the company wrote it. Equivalent notations are compared together; the original wording stays visible.
SEC original
The filing as published on the SEC EDGAR system. “Company original” is the release on the company's own investor site.
Status
One of seven labels set by founder review of the original filings. Definitions: Methodology.

See VSTM in the calendar · Review labels and methodology

Topline results are the main summary results of a clinical trial, released before the full data.A Form 8-K is a report a company files with the SEC to announce a significant event between its regular reports.